ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,117.52
0.00%
US Tech 100
21,573.20
0.39%
다우존스 지수
44,176.65
0.00%
Bitcoin
99,108.92
0.80%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Shattuck Labs Inc (STTK)

  7. Shattuck Labs Inc (STTK) 뉴스

Shattuck Labs Inc

Shattuck Labs Inc (STTK)

NASDAQ
1.29
0.03
(2.38%)
마감 21 2월 6:00AM
15분 지연
1.29
0.00
( 0.00% )
시간외 단일가: 10:19PM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

STTK 뉴스

공식 뉴스 전용

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
09 11월 2024
STTK (2.38%)

Form 8-K - Current report
Edgar (US Regulatory)
01 10월 2024
STTK (2.38%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
02 8월 2024
STTK (2.38%)

Form 8-K - Current report
Edgar (US Regulatory)
02 8월 2024
STTK (2.38%)

Form 8-K - Current report
Edgar (US Regulatory)
14 6월 2024
STTK (2.38%)

Form 8-K/A - Current report: [Amend]
Edgar (US Regulatory)
12 6월 2024
STTK (2.38%)

Form 8-K - Current report
Edgar (US Regulatory)
11 6월 2024
STTK (2.38%)

STTK Discussion

게시물 보기
TrendTrade2016 TrendTrade2016 4 월 전
STTK COMING OFF BOTTOM
👍️0
glenn1919 glenn1919 4 월 전
STTK............................https://stockcharts.com/h-sc/ui?s=STTK&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 월 전
STTK under $4
👍️0
PonkenPlonken PonkenPlonken 9 월 전
absolutely revolutionary data in HR MDS... compare to SOC!!! HMAs show a ORR 30%, CR 10-20%
(also beats venetoclax + HMA in TP53m AML)

Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% –

– Observed 27% initial CR/complete response with incomplete hematologic recovery (CRi) in frontline TP53m AML patients, and 5/11 evaluable patients achieved stable disease with decreasing blast counts and peripheral blood count improvement, these patients continue on treatment
👍️0
Monksdream Monksdream 10 월 전
STTK new 52 week high
👍️0
Monksdream Monksdream 1 년 전
STTK new 52 week high
👍️0
Monksdream Monksdream 1 년 전
STTK new 52 week low
👍️0
tbonaces80 tbonaces80 1 년 전
Takeda gonna tender on next trial fast track
👍️0
tbonaces80 tbonaces80 1 년 전
load it-going to 10+
👍️0
subslover subslover 1 년 전
No fooling? So you say a 1.75% profit for a two-hour trade is a bad trade?
👍️0
tbonaces80 tbonaces80 1 년 전
Bad trade
👍️0
subslover subslover 1 년 전
Ok. I got out of this POS this morning at $5.00, got lucky is all
👍️0
TheFinalCD TheFinalCD 1 년 전
@ 4.29 I was just looking for a move under $4 and it did

small gain, but I didnt know how many borrows I could get if it went against me

sometimes I go short, and get upside down and cant average up, because broker all of a sudden has NO available shares to short= your stuck

so thats why I dont short much
👍️0
subslover subslover 1 년 전
What price did you short?tia
👍️0
TheFinalCD TheFinalCD 1 년 전
I shorted it... Its just Phase 1

AI bot hyper extended the POP

I used to chase these Pase 1 rallys, lost lots of money doing so

some of my biggest losses ever

Phase 1 Gap & Traps
👍️0
subslover subslover 1 년 전
Did you see this open? $7.28! then immediately dropped down to $2.50 omg. I'm in at $3.00 just hoping for the best. Worth a shot
👍️0
TheFinalCD TheFinalCD 1 년 전
https://twitter.com/TigerLineTrades/status/1734900423301988796
👍️0
subslover subslover 1 년 전
$TSOI's new Introducing the ALScell™, also known as the JadiCell™ – Now, these ALScells are not your run-of-the-mill mesenchymal stem cells; they're basically the overachievers of the cellular world. These ALScells have it all – enhanced growth factor production, like they've been hitting the gym and drinking protein shakes on a regular basis. They can secrete exosomes , outshining their stem cell peers who are still trying to figure out how to tie their cellular shoelaces.

But wait, there's more! These ALScells are not just content with being academically gifted; they've got some serious street smarts too. Superior angiogenic and neurogenic abilities mean they're like the cool kids who not only excel in science class but also throw legendary parties in the cellular neighborhood.

And guess what? Exosomes are not just a fancy word; they're the VIP pass to the cure of many cancers. It's like the ALScells are hosting the party, and exosomes are the invitations that cancer cells can't resist.

So, say hello to the ALScell™ – the cellular superhero ready to save the day, one enhanced growth factor at a time, and unlocking cures like a boss!
Bullish
BULLISH
👍️0
Awl416 Awl416 1 년 전
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati
👍️0
Monksdream Monksdream 1 년 전
STTK under $2
👍️0

최근 히스토리

NASDAQ
STTK
Shattuck Labs
NYSE
KN
Knowles
USOTC
SRSG
Spirits Time (PK)
COIN
BMJUSD
BMJ Master Nodes
LSE
0DT1
National Bank Of Belgium
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지